SCHEMBL3252000

SCHEMBL3252000

CN([C]=S)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HTT P42858 1/20 0.42
CA12 O43570 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
FAAH O00519 1/20 0.41
PHGDH O43175 1/20 0.41
MGLL Q99685 1/20 0.41
CA1 P00915 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 5/20 0.36
MAPT P10636 2/20 0.36
HSP90AA1 P07900 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TSHR P16473 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11823858 0.77 ALDH1A1 (0.52) CA2CA9CA1LMNAALDH1A1
SCHEMBL3242840 0.75 MEN1 (0.39) MEN1KMT2AHTTCA12CA2
SCHEMBL2584786 0.75 ACHE (0.44) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL4512814 0.74 MEN1 (0.42) MEN1KMT2AHTTCA12CA2
SCHEMBL6606508 0.74 MEN1 (0.42) MEN1KMT2AHTTCA12CA2
SCHEMBL209159 0.74 KMT2A (0.48) MEN1KMT2AHTTCA12CA2
SCHEMBL1344357 0.74 KMT2A (0.42) MEN1KMT2AHTTCA12CA2
SCHEMBL2858411 0.72 ALDH1A1 (0.39) MEN1KMT2AHTTCA12CA2
Isothiocyanate SCHEMBL2891675 0.72 ALDH1A1 (0.48) MEN1KMT2AHTTCA12CA2
SCHEMBL31058089 0.72 MEN1 (0.41) MEN1KMT2AHTTCA12CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101861093-A The aryloxy alkyl imidazoline that replaces with the haloalkyl of used as pesticides SYNGENTA PARTICIPATIONS AG 2010-10-13 CN claimed
CN-101835758-A Halogenated aryloxy alkyl imidazolines as sterilant SYNGENTA PARTICIPATIONS AG 2010-09-15 CN claimed
CN-101627016-A Compound (I) SYNGENTA PARTICIPATIONS AG 2010-01-13 CN claimed
CN-101610675-A Chemical compounds quinoline derivant and they purposes as agricultural chemicals SYNGENTA PARTICIPATIONS AG (CH) 2009-12-23 CN claimed
US-20140031376-A1 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-01-30 US disclosed
US-8618329-B2 Iminopropene compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-12-31 US disclosed
US-20130150392-A1 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-06-13 US disclosed
US-8410316-B2 Iminopropene compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-02 US disclosed
US-20110319437-A1 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-29 US disclosed
US-8084644-B2 Agricultural pesticide; Wide variety of compounds, for example phenyl N-phenyl-3-(phenylthio)thioacrylimidate; formula X-CH=CH-C(-Y)=N-Z where X, Y and Z are variable SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-27 US disclosed
CN-101861093-A The aryloxy alkyl imidazoline that replaces with the haloalkyl of used as pesticides SYNGENTA PARTICIPATIONS AG 2010-10-13 CN disclosed
CN-101848640-A The aryloxy alkyl imidazoline that replaces with the nitro of used as pesticides SYNGENTA PARTICIPATIONS AG 2010-09-29 CN disclosed
WO-2007063702-A2 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-07 WO disclosed
US-6562849-B1 Amine compound or pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc. SANKYO COMPANY, LIMITED (JP) 2003-05-13 US disclosed
US-20030078426-A1 Amine derivative compounds SANKYO COMPANY, LIMITED (JP) 2003-04-24 US disclosed
EP-1167366-A1 AMINE DERIVATIVES Sankyo Company, Limited (JP) 2002-01-02 EP disclosed
US-4933355-A ALDOSE REDUCTASE INHIBITORS SANKYO COMPANY LIMITED (JP) 1990-06-12 US disclosed
EP-0337819-A1 Thiazole derivatives, their preparation and their use in the treatment of diabetes complications Sankyo Company Limited (JP) 1989-10-18 EP disclosed
US-4008228-A Process for preparing 3-methyl-3-cephem antibiotics ELI LILLY AND COMPANY (US) 1977-02-15 US disclosed
US-3979369-A DIENE POLYMER MONSANTO COMPANY (US) 1976-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140031376-A1 IMINOPROPENE COMPOUND AND USE THEREOF IMPA1, INPP5A, CTRL MEN1 55/4885KMT2A 1674/4885HTT 1657/4885
US-20130150392-A1 IMINOPROPENE COMPOUND AND USE THEREOF IMPA1, INPP5A, CTRL MEN1 55/4885KMT2A 1674/4885HTT 1657/4885
US-20030078426-A1 Amine derivative compounds H1-10, APOB, PRMT1 MEN1 300/4885KMT2A 85/4885HTT 3024/4885
US-20110319437-A1 IMINOPROPENE COMPOUND AND USE THEREOF IMPA1, INPP5A, CTRL MEN1 55/4885KMT2A 1674/4885HTT 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.